Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Pharmacoepidemiology and Drug Safety
|
March 6, 2018
Sequential surveillance for drug safety in a regulatory environment
David Martin, Joshua J Gagne, Susan Gruber, et al.
Pharmacoepidemiology and Drug Safety
|
July 16, 2016
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association
Susan Gruber, Aloka Chakravarty, Susan R Heckbert, et al.
Epidemiology (Cambridge, Mass.)
|
August 26, 2020
Consequences of Depletion of Susceptibles for Hazard Ratio Estimators Based on Propensity Scores
Bruce Fireman, Susan Gruber, Zilu Zhang, et al.
Statistics in Medicine
|
June 25, 2020
Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare
Susan Gruber, Douglas Krakower, John T Menchaca, et al.
American Journal of Epidemiology
|
March 20, 2018
Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses
Shirley V Wang, Yinzhu Jin, Bruce Fireman, et al.
American Journal of Epidemiology
|
March 4, 2025
Note on targeted learning with an undersmoothed Lasso propensity score model for large-scale covariate adjustment in health care database studies
Richard Wyss, Mark van der Laan, Susan Gruber, et al.
American Journal of Epidemiology
|
March 22, 2024
Targeted learning with an undersmoothed LASSO propensity score model for large-scale covariate adjustment in health-care database studies
Richard Wyss, Mark van der Laan, Susan Gruber, et al.
Pharmacoepidemiology and Drug Safety
|
September 30, 2014
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems
Carlos Bell, Aloka Chakravarty, Susan Gruber, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2025
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Susan Gruber, Hana Lee, et al.
Blood Advances
|
August 28, 2025
Efficacy and Safety of Belumosudil as Compared with Best Available Therapy for the Treatment of cGVHD in the US
Kevin Hall, Aleksandr Lazaryan, Mark van Der Laan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Pharmacoepidemiology and Drug Safety
|
March 6, 2018
Sequential surveillance for drug safety in a regulatory environment
David Martin, Joshua J Gagne, Susan Gruber, et al.
Pharmacoepidemiology and Drug Safety
|
July 16, 2016
Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association
Susan Gruber, Aloka Chakravarty, Susan R Heckbert, et al.
Epidemiology (Cambridge, Mass.)
|
August 26, 2020
Consequences of Depletion of Susceptibles for Hazard Ratio Estimators Based on Propensity Scores
Bruce Fireman, Susan Gruber, Zilu Zhang, et al.
Statistics in Medicine
|
June 25, 2020
Using electronic health records to identify candidates for human immunodeficiency virus pre-exposure prophylaxis: An application of super learning to risk prediction when the outcome is rare
Susan Gruber, Douglas Krakower, John T Menchaca, et al.
American Journal of Epidemiology
|
March 20, 2018
Relative Performance of Propensity Score Matching Strategies for Subgroup Analyses
Shirley V Wang, Yinzhu Jin, Bruce Fireman, et al.
American Journal of Epidemiology
|
March 4, 2025
Note on targeted learning with an undersmoothed Lasso propensity score model for large-scale covariate adjustment in health care database studies
Richard Wyss, Mark van der Laan, Susan Gruber, et al.
American Journal of Epidemiology
|
March 22, 2024
Targeted learning with an undersmoothed LASSO propensity score model for large-scale covariate adjustment in health-care database studies
Richard Wyss, Mark van der Laan, Susan Gruber, et al.
Pharmacoepidemiology and Drug Safety
|
September 30, 2014
Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems
Carlos Bell, Aloka Chakravarty, Susan Gruber, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2025
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Susan Gruber, Hana Lee, et al.
Blood Advances
|
August 28, 2025
Efficacy and Safety of Belumosudil as Compared with Best Available Therapy for the Treatment of cGVHD in the US
Kevin Hall, Aleksandr Lazaryan, Mark van Der Laan, et al.
Page
of 6